Robert Kajubi
About Robert Kajubi
Robert Kajubi is a Senior Counsel specializing in Innovation Law at Bristol Myers Squibb in Princeton, New Jersey. He has extensive experience in patent law and intellectual property management, having worked at Boehringer Ingelheim, Sanofi, and other firms.
Company
Robert Kajubi is currently working at Bristol Myers Squibb as Senior Counsel/Innovation Law in Princeton, New Jersey, United States. His role involves managing intellectual property due diligence for AI-based drug discovery technologies, advising senior management on patent validity and enforceability for potential licensing agreements, and providing loss of exclusivity (LOE) analyses related to potential collaboration agreements.
Previous Title at Boehringer Ingelheim
Robert Kajubi worked at Boehringer Ingelheim as Senior Patent Counsel from 2020 to 2021 for 1 year in Ridgefield, Connecticut, United States. During his tenure, he focused on handling patent-related issues and advising on intellectual property matters.
Previous Roles at Sanofi
Robert Kajubi had multiple roles at Sanofi, starting as Director (Internal Medicine) from 2006 to 2008 in Greater New York City Area. He then served as Senior Director (Litigation) from 2008 to 2013. Finally, he held the position of Lead U.S. Patent Counsel / Sr. Patent Counsel (Global Emerging Markets) from 2013 to 2019 in Bridgewater, NJ, focusing on directing patent strategies and legal counsel in various markets.
Education and Expertise
Robert Kajubi holds an LL.M. in Trial Advocacy/Litigation from Temple University - James E. Beasley School of Law, a J.D. with a concentration in Intellectual Property/Patent Law from the University of New Hampshire, and a B.S. in Chemistry from Temple University. He also studied Basic Medical Sciences at Wayne State University School of Medicine. His expertise lies in intellectual property law, patent strategies, and litigation.